There was also no change in the trajectory of tumor volume over time in the mice following ELP-VEGF injection at any dose as assessed by both caliper measurement (Fig. 7b, F (3,34) = 0.24; p = 0.87)) and tumor bioluminescence (Fig. 7c, F (3,34) = 1.44; p = 0.25). The gene discussed is VEGFA; the disease is neoplasm.